Treatment Effects of Sacubitril/Valsartan Compared With Valsartan by Ejection Fraction in Patients With Recent Hospitalization

被引:0
|
作者
Bhatt, Ankeet S. [1 ]
Claggett, Brian L. [1 ]
Packer, Milton [2 ]
Lefkowitz, Martin P. [3 ]
Zile, Michael R. [4 ]
McMurray, John J. V. [5 ]
Solomon, Scott D. [1 ]
Vaduganathan, Muthiah [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc Med, Dept Med, Harvard Med Sch, Boston, MA 02115 USA
[2] Baylor Univ, Baylor Heart & Vasc Inst, Med Ctr, Dallas, TX USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Med Univ South Carolina, Charleston & Ralph H Johnston Vet Adm Med Ctr, Charleston, SC USA
[5] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
关键词
D O I
10.1016/j.cardfail.2021.05.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1027 / 1030
页数:4
相关论文
共 50 条
  • [1] Prior Heart Failure Hospitalization, Clinical Outcomes, and Effect of Sacubitril/Valsartan Compared With Valsartan in Heart Failure With Preserved Ejection Fraction
    Vaduganathan, Muthiah
    Claggett, Brian
    Anker, Stefan D.
    Perrone, Sergio V., Sr.
    Janssens, Stefan P.
    Milicic, Davor
    Arango, Juan L.
    Packer, Milton
    McMurray, John J.
    Solomon, Scott
    CIRCULATION, 2019, 140 (25) : E995 - E996
  • [2] Effects on sacubitril/valsartan on natriuretic peptides in patients with a reduced ejection fraction
    Lamaida, Norman
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [3] Effects on sacubitril/valsartan on natriuretic peptides in patients with a reduced ejection fraction
    Lamaida, Norman
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [4] LBCT: Effects of Sacubitril/Valsartan in Women Compared to Men With Heart Failure and Preserved Ejection Fraction
    McMurray, John J.
    Lam, Carolyn S.
    McGrath, Martina
    Pardeep, Jhund S.
    O'Meara, Eileen
    Packer, Milton, Jr.
    Redfield, Margaret M.
    Shi, Victor
    Sweitzer, Nancy K.
    Solomon, Scott D.
    CIRCULATION, 2019, 140 (25) : E994 - E995
  • [5] Sacubitril/valsartan as a Treatment for Resistant Hypertension in Patients With Heart Failure and Preserved Ejection Fraction
    Jhund, Pardeep S.
    Alice, M.
    Pfeffer, Marc A.
    Zannad, Faiez
    Lefkowitz, Martin P.
    Shi, Victor
    Vardeny, Orly
    Solomon, Scott
    McMurray, John J.
    CIRCULATION, 2020, 142
  • [6] Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    Butt, Jawad H.
    Dewan, Pooja
    Jhund, Pardeep S.
    Anand, Inder S.
    Atar, Dan
    Ge, Junbo
    Desai, Akshay S.
    Echeverria, Luis E.
    Kober, Lars
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Rouleau, Jean L.
    Sim, David
    Van Veldhuisen, Dirk J.
    Vrtovec, Bojan
    Zannad, Faiez
    Zile, Michael R.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Solomon, Scott D.
    McMurray, John J., V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : 1130 - 1143
  • [7] Recovery of left ventricular ejection fraction in patients treated with sacubitril/valsartan
    Joana Mesquita Guimaraes, J.
    Fernandes, D.
    Costa, G.
    Monteiro, E.
    Castro, G.
    Goncalves, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 252 - 252
  • [8] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [9] Effects of Sacubitril-Valsartan Compared With Enalapril on Pulmonary Artery Pressure in Patients With Heart Failure and Reduced Ejection Fraction
    Desai, Akshay S.
    Shah, Amil M.
    Mitchell, Gary F.
    Claggett, Brian L.
    Fang, James C.
    Abbas, Cheryl A.
    Rocha, Ricardo A.
    Solomon, Scott D.
    CIRCULATION, 2019, 140
  • [10] Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction
    Raschi, Emanuel
    Diemberger, Igor
    Sabatino, Mario
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Potena, Luciano
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) : 303 - 320